<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17662331</PMID><DateCompleted><Year>2007</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0042-6822</ISSN><JournalIssue CitedMedium="Print"><Volume>368</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses.</ArticleTitle><Pagination><StartPage>376</StartPage><EndPage>387</EndPage><MedlinePgn>376-87</MedlinePgn></Pagination><Abstract><AbstractText>In this study, we successfully established retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope (PrM/E) proteins of each of the four serotypes of dengue viruses, which caused the most important arboviral diseases in this century. Co-sedimentation of the dengue E protein and HIV-1 core proteins by sucrose gradient analysis of the pseudotype reporter virus of dengue virus type 2, D2(HIVluc), and detection of HIV-1 core proteins by immunoprecipitation with anti-E monoclonal antibody suggested that dengue viral proteins were incorporated into the pseudotype viral particles. The infectivity in target cells, as assessed by the luciferase activity, can be inhibited by the lysosomotropic agents, suggesting a pH-dependent mechanism of entry. Amino acid substitutions of the leucine at position 107, a critical residue at the fusion loop of E protein, with lysine resulted in severe impairment in infectivity, suggesting that entry of the pseudotype reporter virus is mediated through the fusogenic properties of E protein. With more and more dengue viral sequences available from different outbreaks worldwide, this sensitive and convenient tool has the potential to facilitate molecular characterization of the PrM/E proteins of dengue field isolates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Hsien-Ping</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, College of Medicine, National Taiwan University, No 1 Sec1 Jen-Ai Rd, Taipei 100, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Szu-Chia</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Chwan-Chuen</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074932">prM protein, Flavivirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="Y">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020014" MajorTopicYN="N">K562 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="Y">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="Y">Virion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>12</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17662331</ArticleId><ArticleId IdType="pmc">PMC7126519</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2007.06.026</ArticleId><ArticleId IdType="pii">S0042-6822(07)00426-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allison S.L., Stadler K., Mandl C.W., Kunz C., Heniz F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 1995;69:5816&#x2013;5820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189449</ArticleId><ArticleId IdType="pubmed">7637027</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison S.L., Stiasny K., Stadler K., Mandl C.W., Heinz F.X. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 1999;73:5605&#x2013;5612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112618</ArticleId><ArticleId IdType="pubmed">10364309</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison S.L., Schalich J., Stiasny K., Mandl C.W., Heinz F.X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 2001;75:4268&#x2013;4275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114172</ArticleId><ArticleId IdType="pubmed">11287576</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R., Wang S., Osiowy C., Issekutz A.C. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J. Virol. 1997;71:4226&#x2013;4232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191637</ArticleId><ArticleId IdType="pubmed">9151809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartosch B., Dubuisson J., Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1&#x2013;E2 envelope protein complexes. J. Exp. Med. 2003;197:633&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193821</ArticleId><ArticleId IdType="pubmed">12615904</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier C., Takeuchi Y., Towers G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U.S.A. 2002;99:11920&#x2013;11925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129369</ArticleId><ArticleId IdType="pubmed">12154231</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaney J.E., Jr., Hanson C.T., Firestone C.Y., Hanley K.A., Murphy B.R., Whitehead S.S. Genetically modified, live attenuated dengue virus type 3 vaccine candidates. Am. J. Trop. Med. Hyg. 2004;71:811&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">15642976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray M., Lai C.J. Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc. Natl. Acad. Sci. U.S.A. 1991;88:10342&#x2013;10346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC52924</ArticleId><ArticleId IdType="pubmed">1682924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray M., Men R., Tokimatsu I., Lai C.J. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J. Virol. 1998;72:1647&#x2013;1651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124649</ArticleId><ArticleId IdType="pubmed">9445071</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonocore L., Blight K.J., Rice C.M., Rose J.K. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J. Virol. 2002;76:6865&#x2013;6872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136334</ArticleId><ArticleId IdType="pubmed">12072487</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrington C.V.F., Foster J.E., Pybus O.G., Bennett S.N., Holmes E.C. Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J. Virol. 2005;79:14680&#x2013;14687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1287558</ArticleId><ArticleId IdType="pubmed">16282468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., Goldsmith M.A. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell. 2001;106:117&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.J., Hunt A.R., Holmes D.A., Springfield T., Chiueh T.S., Roehrig J.T., Gubler D.J. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology. 2003;306:170&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987;7:2745&#x2013;2752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC367891</ArticleId><ArticleId IdType="pubmed">3670292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Kawano H., Men R., Clark D., Lai C.J. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J. Virol. 1995;69:5186&#x2013;5190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189343</ArticleId><ArticleId IdType="pubmed">7609092</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">7531918</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill W.D., Chang G.J.J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 2004;78:13975&#x2013;13986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC533943</ArticleId><ArticleId IdType="pubmed">15564505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin J., Zhang X.Y., Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 2005;5(4):387&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1368960</ArticleId><ArticleId IdType="pubmed">16101513</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">8649511</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 1997;388:296&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">9230441</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M.S., Edgil D., Roberts T.G., Lu B., Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 2000;74:7814&#x2013;7823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112311</ArticleId><ArticleId IdType="pubmed">10933688</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed E.O., Martin M.A. HIVs and their replication. In: Knipe D.M., Howley P.M., editors. Fields Virology. 4th ed. Lippincott Raven; Philadelphia, Pa: 2001. pp. 1971&#x2013;2041.</Citation></Reference><Reference><Citation>Fukushi S., Mizutani T., Saijo M., Matsuyama S., Miyajima N., Taguchi F., Itamura S., Kurane I., Morikawa S. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 2005;86:2269&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pubmed">16033974</ArticleId></ArticleIdList></Reference><Reference><Citation>Giroglou T., Cinatl J., Jr., Rabenau H., Drosten C., Schwalbe H., Doerr H.W., von Laer D. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J. Virol. 2004;78:9007&#x2013;9015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC506966</ArticleId><ArticleId IdType="pubmed">15308697</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S., Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 2006;19:429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">16940865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano R.C., Pryor M.J., Cauchi M.R., Wright P.J., Davidson A.D. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J. Gen. Virol. 1998;79:437&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">9519821</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827812</ArticleId></ArticleIdList></Reference><Reference><Citation>Guirakhoo F., Hunt A.R., Lewis J.G., Roehrig J.T. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology. 1993;194:219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">8480420</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Kouri G. Dengue: an update. Lancet Infect. Dis. 2002;2:33&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">11892494</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanika A., Larisch B., Steinmann E., Schwegmann-We&#xe2;els C., Herrler G., Zimmer G. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J. Gen. Virol. 2005;86:1455&#x2013;1465.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831958</ArticleId></ArticleIdList></Reference><Reference><Citation>He R.T., Innis B.L., Nisalak A., Usawattanakul W., Wang S., Kalayanarooj S., Anderson R. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J. Med. Virol. 1995;45:451&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">7666046</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 1982;31:830&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pubmed">6285749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh P.K., Chang S.C., Huang C.C., Lee T.T., Hsiao C.W., Kou Y.H., Chen I.Y., Chang C.K., Huang T.H., Chang M.F. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J. Virol. 2005;79:13848&#x2013;13855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1280188</ArticleId><ArticleId IdType="pubmed">16254320</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U.S.A. 2003;100:7271&#x2013;7276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165865</ArticleId><ArticleId IdType="pubmed">12761383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor M., Zhang L., Mohan P.M., Padmanabhan R. Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain) Gene. 1995;162:175&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">7557426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano H., Rostapshov V., Rosen L., Lai C.J. Genetic determinants of dengue type 4 virus neurovirulence for mice. J. Virol. 1993;67:6567&#x2013;6575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC238094</ArticleId><ArticleId IdType="pubmed">8411360</ArticleId></ArticleIdList></Reference><Reference><Citation>Keelapang P., Sriburi R., Supasa S., Panyadee N., Songjaeng A., Jairungsri A., Puttikhunt C., Kasinrerk W., Malasit P., Sittisombut N. Alterations of pr&#x2013;M cleavage and virus export in pr&#x2013;M junction chimeric dengue viruses. J. Virol. 2004;78:2367&#x2013;2381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC369205</ArticleId><ArticleId IdType="pubmed">14963133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology. 1997;230:300&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">9143286</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi E., Pincus S., Paoletti E., Shope R.E., Burrage T., Mason P.W. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology. 1992;188:714&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">1585642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I., Kontny U., Janus J., Ennis F.A. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch. Virol. 1990;110:91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">2178591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.J., Zhao B.T., Hori H., Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. U.S.A. 1991;88:5139&#x2013;5143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC51827</ArticleId><ArticleId IdType="pubmed">2052593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.N., Wang W.K., Fan W.S., Twu S.J., Chen S.C., Sheng M.C., Chen M.Y. Determination of human immunodeficiency virus type 1 subtypes in Taiwan by vpu gene analysis. J. Clin. Microbiol. 2000;38:2468&#x2013;2474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86944</ArticleId><ArticleId IdType="pubmed">10878027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.R., Hsieh S.C., Yueh Y.Y., Lin T.H., Chao D.Y., Chen W.J., King C.C., Wang W.K. Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution. J. Virol. 2004;78:12717&#x2013;12721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC525091</ArticleId><ArticleId IdType="pubmed">15507664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach B.D., Rice C.M. Flaviviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., editors. Fields Virology. 4th ed. Lippincott Raven; Philadelphia, Pa: 2001. pp. 991&#x2013;1041.</Citation></Reference><Reference><Citation>Liu M.Y., Hu H.P., Hsu T.Y., Chen J.Y. Site-directed mutagenesis in a conserved motif of Epstein&#x2013;Barr virus DNase that is homologous to the catalytic centre of type II restriction endonuclease. J. Gen. Virol. 2003;84:677&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pubmed">12604820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M., Kersten D.B., Kamrud K.I., Wool-Lewis R.J., Schmaljohn C., Gonzalez-Scarano F. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Res. 1999;64:23&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10500280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason P.W., Pincus S., Fournier M.J., Mason T.L., Shope R.E., Paoletti E. Japanese encephalitis virus&#x2013;vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology. 1991;180:294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">1845826</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura Y., Tani H., Suzuki K., Kimura-Someya T., Suzuki T., Aizaki H., Ishii K., Moriishi K., Robison C.S., Whitt M.A., Miyamura T. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology. 2001;286:263&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">11485395</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 1986;55:663&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">2874766</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427:313&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">14737159</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore M.J., Dorfman T., Li W., Wong S.K., Li Y., Kuhn J.H., Coderre J., Vasilieva N., Han Z., Greenough T.C., Farzan M., Choe H. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J. Virol. 2004;78:10628&#x2013;10635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC516384</ArticleId><ArticleId IdType="pubmed">15367630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat. Rev., Microbiol. 2005;3:13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">15608696</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray J.M., Aaskov J.G., Wright P.J. Processing of the dengue virus type 2 proteins prM and C&#x2013;prM. J. Gen. Virol. 1993;74:175&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">8429301</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y., Wang P., Shi X., Wang G., Chen J., Zheng A., Wang W., Wang Z., Qu X., Luo M., Tan L., Song X., Yin X., Chen J., Ding M., Deng H. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem. Biophys. Res. Commun. 2004;321:994&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092805</ArticleId><ArticleId IdType="pubmed">15358126</ArticleId></ArticleIdList></Reference><Reference><Citation>Purdy D.E., Chang G.J.J. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology. 2005;333:239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">15721358</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri B., Polo S., Hayes C.G., Falgout B. Construction of a full length infectious clone for dengue-1 virus Western Pacific, 74 strain. Virus Genes. 2000;20:57&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">10766307</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph V.B., Stollar V. Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. J. Gen. Virol. 1990;71:1845&#x2013;1850.</Citation><ArticleIdList><ArticleId IdType="pubmed">2167941</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph V.B., Winkler G., Stollar V. Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology. 1990;174:450&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">2154882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose J.K., Whitt M.A. Rhabdoviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., editors. Fields Virology. 4th ed. Lippincott Raven; Philadelphia, Pa: 2001. pp. 1221&#x2013;1277.</Citation></Reference><Reference><Citation>Stadler K., Allison S.L., Schalich J., Heinz F.X. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 1997;71:8475&#x2013;8481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192310</ArticleId><ArticleId IdType="pubmed">9343204</ArticleId></ArticleIdList></Reference><Reference><Citation>Schalich J., Allison S.L., Stiasny K., Mandl C.W., Kunz C., Heinz F.X. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 1996;70:4549&#x2013;4557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190391</ArticleId><ArticleId IdType="pubmed">8676481</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 2004;101:4240&#x2013;4245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC384725</ArticleId><ArticleId IdType="pubmed">15010527</ArticleId></ArticleIdList></Reference><Reference><Citation>Spearman P., Ratner L. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J. Virol. 1996;70:8187&#x2013;8194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190900</ArticleId><ArticleId IdType="pubmed">8892951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriburi R., Keelapang P., Duangchinda T., Pruksakorn S., Maneekarn N., Malasit P., Sittisombut N. Construction of infectious dengue 2 virus cDNA clones using high copy number plasmid. J. Virol. Methods. 2001;92:71&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.K., Chen H.L., Yang C.F., Hsieh S.C., Juan C.C., Chang S.M., Yu C.C., Lin L.H., Huang J.H., King C.C. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 2006;43:1023&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.K., Dudek T., Essex M., Lee T.H. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications. Proc. Natl. Acad. Sci. U.S.A. 1999;96:4458&#x2013;4562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16371</ArticleId><ArticleId IdType="pubmed">10200301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., He R., Anderson R. PrM- and cell-binding domains of the dengue virus E protein. J. Virol. 1999;73:2547&#x2013;2551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104503</ArticleId><ArticleId IdType="pubmed">9971841</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead S.S., Falgout B., Hanley K.A., Blaney J.J., Jr., Markoff L., Murphy B.R. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3&#x2032; untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 2003;77:1653&#x2013;1657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140839</ArticleId><ArticleId IdType="pubmed">12502885</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead S.S., Hanley K.A., Blaney J.E., Gilmore L.E., Jr., Elkins W.R., Murphy B.R. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine. 2003;21:4307&#x2013;4316.</Citation><ArticleIdList><ArticleId IdType="pubmed">14505913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool-Lewis R.J., Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 1998;72:3155&#x2013;3160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109772</ArticleId><ArticleId IdType="pubmed">9525641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Mammen M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Monkongdee P., Nimmannitya S., Kalayanarooj S., Holmes E.C. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J. Virol. 2005;79:15123&#x2013;15130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1316048</ArticleId><ArticleId IdType="pubmed">16306584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Li L., Woodson S.E., Huang C.Y.H., Kinney R.M., Barrett A.D.T., Beasley D.W.C. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology. 2006;353:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">16806383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>